Don C.

Lakewood, OH

Don’s Testimonial for Pulmonary Fibrosis & COPD Treatment

Age: 61  |  Location: Lakewood, OH  |  Condition: Pulmonary Fibrosis, COPD

After years of working in construction and smoking cigarettes, Don C. was diagnosed with COPD and pulmonary fibrosis. As his illness progressed, Don found himself relying on supplemental oxygen around the clock. Even getting out of bed became a challenge. Don’s doctors and specialists recommended a lung transplant, but after researching the pros and cons of such a drastic procedure, he decided to try something less invasive. Don contacted the Lung Institute. Following his cellular treatment, Don’s lung function has improved from 30 percent to 34 percent. He no longer needs oxygen and looks forward to continued improvement. Don says his life is better now, and he’s amazed at how well he can breathe.

If you or someone you love has COPD, pulmonary fibrosis or another chronic lung disease, and would like to see improvements like Don’s, contact us at (800) 729-3065 to learn more about our treatment options.

Are you a candidate? Call (800) 729-3065 to find out.

Nancy H.
Bellingham, WA
David V.
Englewood, FL
Herbert K.
Keller, TX
Don C.
Lakewood, OH
Kathleen B.
Amherst, OH
Denise F.
Smiths Creek, MI
Judy Q.
French Village, MO
Penny K.
Omaha, NE
Ronnie G.
Warren, TX
Bill B.
Wellsboro, PA
Joseph O.
Selden, NY
Rhonda S.
Macomb, MI
Tammi S.
Cleveland, OH
Becky D.
Schererville, IN
Rickie S.
Elizabeth City, NC
Brad E.
Nashville, TN
Paul B.
Chagrin Falls, OH
Michael F.
Georgetown, TX
Lois S.
Sun City, AZ
Karl T.
Hampstead, NC
June B.
Madeira Beach, FL
Jim D.
Boca Raton, FL
Marvin S.
Lakeland, FL
Vickie B.
San Antonio, TX
Audrey S.
Fairbanks, AK
Linus S.
Hays, KS

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.